Terumo | 4543 - Ebitda


Terumo reported JPY116.67B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Astellas Pharma JPY 235.24B 136.32B Jun/2026
Chugai Pharma JPY 193.44B 23.07B Sep/2026
Daiichi Sankyo JPY 116.06B 14.46B Jun/2026
Eisai JPY 34.15B 34.48B Jun/2026
Kyowa Hakko Kirin JPY 53.91B 36.74B Jun/2026
M3 JPY 35.31B 20.26B Jun/2026
Olympus JPY 46.26B 2.85B Jun/2026
Otsuka Holdings JPY 174.82B 14.19B Sep/2026
Shionogi JPY 87.79B 59.04B Jun/2026
Sumitomo Dainippon JPY 28.97B 27.16B Sep/2026
Takeda JPY 369.75B 5.29B Sep/2026
Terumo JPY 116.67B 58.79B Jun/2026